About these studies

The BE OPTIMAL and BE COMPLETE studies are testing whether an investigational study drug called bimekizumab is safe and effective for treating active psoriatic arthritis.

If you:

• Are 18 years of age or older
• Have been diagnosed with active psoriatic arthritis
• Have had psoriatic arthritis for at least 6 months
• Have at least 1 psoriatic lesion and/or a history of psoriasis

then you may be able to take part.*

*Other medical criteria must be met before you can join one of these studies; these will be assessed by the study team.